Last update 12 May 2025

GD2 chimeric antigen receptor-expressing peripheral blood T cells(Royal Adelaide Hospital)

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms-
Target
GD2
Action
modulators
Mechanism
GD2 modulators(Disialoganglioside GD2 modulators)
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication
Melanoma
Inactive Indication-
Originator Organization
Royal Adelaide HospitalRoyal Adelaide Hospital
Active Organization
Royal Adelaide HospitalRoyal Adelaide Hospital
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with GD2 chimeric antigen receptor-expressing peripheral blood T cells(Royal Adelaide Hospital)
ACTRN12622001514796
/ RecruitingNot ApplicableIIT
KARPOS - A Phase 1, Single-Centre, Non-randomised, Open-labelled, Escalating Dose Study of Autologous GD2-Specific Chimeric Antigen Receptor-expressing Peripheral Blood T cells in Patients with Recurrent GD2-positive Glioblastoma Multiforme
ACTRN12613000198729
/ Active, not recruitingPhase 1IIT
A phase I study of the safety and immune effects of an escalating dose of autologous GD2 chimeric antigen receptor-expressing peripheral blood T cells in patients with GD2-positive metastatic melanoma and refractory solid tumours
100 Clinical Results associated with GD2 chimeric antigen receptor-expressing peripheral blood T cells(Royal Adelaide Hospital)
Login to view more data
100 Translational Medicine associated with GD2 chimeric antigen receptor-expressing peripheral blood T cells(Royal Adelaide Hospital)
Login to view more data
100 Patents (Medical) associated with GD2 chimeric antigen receptor-expressing peripheral blood T cells(Royal Adelaide Hospital)
Login to view more data
100 Deals associated with GD2 chimeric antigen receptor-expressing peripheral blood T cells(Royal Adelaide Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MelanomaPhase 1
Australia
Royal Adelaide HospitalRoyal Adelaide Hospital
01 Oct 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free